Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
about
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusThe role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer PatientsImpact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerMetabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysisGermline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerA targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Have we given up on a cure for ovarian cancer?Ovarian cancer survival by tumor dominance, a surrogate for site of origin.Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcomeClinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients.Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.Are two-centimeter breast cancers large or small?A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.BRCA and Early Events in the Development of Serous Ovarian Cancer.Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.PARP inhibition and synthetic lethality in ovarian cancer.Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.Living With Genetic Vulnerability: a Life Course Perspective.CTCF promotes epithelial ovarian cancer metastasis by broadly controlling the expression of metastasis-associated genes.Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Response.Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study.When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population
P2860
Q28307436-0C153053-887B-4D00-A42B-456FF9DACF37Q33553318-4068F585-D018-46D2-A816-34FBB0E35606Q33584055-1115346F-05E7-4519-8BDE-FA17B8CE741BQ33633402-BC14D06F-ECCB-4FE1-A287-82C4A63A5C3FQ33704050-5C198F38-8192-432E-AB04-FDB4F2DC125EQ33762042-41BE9434-5B38-44D0-982D-7CBF9ED833D1Q33952816-88F89D97-C2C9-4D5E-8282-A55CD8008CEFQ34455481-144E8D07-C967-4C7E-8CDA-B9B1FADB418AQ34860429-30E55036-3BBD-41C5-811D-591F2D36FF37Q35114576-044D9BAB-C046-42A4-B5E7-EE5183D5DB6FQ35223166-F2F0CE18-660D-4472-8BFB-EEBB31E2D0D3Q35690548-33A33090-0CF1-4E36-B3EC-EA3445314980Q35714581-977F29F2-0D1E-40DA-9182-F5FF097333CEQ36032691-2652D7B1-7675-4824-9F88-1306B430F259Q36246404-1FDF13A2-B62D-4FD5-9035-31C3D9FB9E64Q36446316-1FDF4406-3F7F-4AF0-8270-FB77AFCB9D40Q36979335-93347848-32E6-479B-9AAD-D229A1A8A0F9Q36983535-4D651EC3-6CEC-422F-B55C-14743914B9ACQ37056869-C23A2ED3-8855-42D5-ABC5-E8FF0D0F65DDQ37390796-40DA5F5D-23B3-41A1-A61C-B6647CDBAACDQ37513137-3883AAF6-8949-4863-98D8-B08C4F467160Q37583113-E0F16D9E-0691-42CB-A68C-0C110F7430A7Q37702214-0AFD1641-6FEC-483C-BA10-917FB3138C0DQ38225315-7C03A16B-5FCD-45CA-9BD4-B7F3A9BCDBFCQ38609944-1EFF62EC-A224-494A-9CDC-DA3F931733EEQ38711217-26FA7FF6-C494-490E-9188-F50B3D8624F4Q40332287-485EAE4B-51D7-4FE8-9E2C-CD012CFAFC17Q40590078-E5D9C173-05EC-43EE-900E-3F1B9594A625Q41924394-6C1F3B25-B4A3-4994-810E-B2B480D8EBF1Q42555674-BE89733C-97CB-489B-BBD9-A4149F893AAEQ44655765-F354B544-8A69-4903-8EE2-A0BBC0B8DC0AQ47101331-4D09F7B6-AC8D-4216-A61E-9FFD2E827675Q48124146-CB1727AF-FE42-4EC5-9065-585FD856359FQ52723773-E72BCCFA-3C2C-4454-B4F6-133217F16185Q52941950-C4D5C35A-27D8-4379-B404-5319AABD724FQ55397998-3F78C706-F087-4330-8DFD-99F6A37F0B51Q58786178-ACDA771A-104C-4F46-B12C-C09850250CA9
P2860
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@ast
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@en
type
label
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@ast
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@en
prefLabel
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@ast
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@en
P2093
P2860
P356
P1476
Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2
@en
P2093
Barry Rosen
Harvey A Risch
Isabel Fan
Joel Moody
John R McLaughlin
Patricia A Shaw
Thomas A Sellers
P2860
P304
P356
10.1093/JNCI/DJS494
P407
P577
2012-12-20T00:00:00Z